Skip to content
False

“A Cold Shot Cures a Cold”: A False Claim, and What Trials Say About the “Power” of the Vein

“Forget the pills, take a shot and you'll be back on your feet” is advice that returns with the first chill of every year. We test two claims: that a “cold shot” cures a cold, and that an injection is inherently stronger than tablets. Verdict: false. The evidence lies in the mixture itself, in randomized trials comparing vein with mouth, and in an official Egyptian guide. The route of a medicine is the doctor's decision alone.

Editorial Board·Published November 22, 2026·9 min read
أربع حقن طبية بلاستيكية بأحجام مختلفة، إبرة كل منها داخل غطاء بلاستيكي شفاف، مرصوصة بشكل مائل متوازٍ على سطح قماشي أبيض، ولا يظهر على أسطوانتها سوى تدريج القياس بالمليلتر بلا اسم تجاري مقروء ولا دواء بداخلها.
Intropin / Wikimedia Commons (CC BY-SA 3.0)

Around this time every year, when a household begins assigning roles around a single patient, with a mug of hot lemon, an extra blanket and a hoarse voice apologizing for missing work in the morning, the advice arrives by phone from a relative who is certain of it: “Forget the pills, take a shot and you'll be back on your feet.” The line is handed down, and behind it sits an older belief: that an injection is inherently stronger than a tablet, and that whatever enters the vein works faster and harder than what is swallowed with a glass of water. It resurfaces every winter, and for some people it has become a substitute for seeing a doctor rather than a route to one.

Today we examine two specific statements and nothing beyond them. First, that the “cold shot” requested over the pharmacy counter cures a common cold. Second, that “an injection is inherently stronger than tablets.” The timing of this piece is deliberate. Each year the world marks World Antimicrobial Resistance Awareness Week, from November 18 to 24, and for the 2026 edition the four organizations involved, covering food and agriculture, the environment, human health and animal health, have chosen the slogan “One Health, one action: let us prevent antimicrobial resistance now,” according to the campaign guide published on the World Health Organization's website. That four-way partnership is exactly why the slogan speaks of “One Health.”

Our verdict on both claims together: false. No injection cures a cold, and there is no basis for the idea that the intravenous route is stronger in itself. But the limits of this verdict matter just as much. It applies to what is requested at a pharmacy without a diagnosis. It does not apply to injections as a form of treatment, or to a doctor's prescription. On August 17, 2026, in our “Debunked” section, we examined a related claim, that antibiotics treat colds, and readers who want the details of that question should return to it. Today's question is different: not which drug, but what the injection is, how it is given, what it is said to contain, and the old belief in the “power” of the needle. We will touch the general argument only as far as the injection itself requires.

Let us start with what is said to be inside it. In a report published by Ahram Gate on November 26, 2025, Dr. Amgad al-Haddad, a consultant in allergy and immunology, described what he called the “cold shot” circulating in pharmacies as usually combining an antibiotic, a cortisone and a strong painkiller. This needs to be recorded precisely: it is one consultant's description of the most commonly circulated mixture as he sees it. It is not an approved standard formulation, nor a single recipe used everywhere. For that reason this article will not name any drug, dose or combination that could be copied. The aim is to understand the logic, not to hand out a prescription.

Each part of that description is a problem. The antibiotic argument collapses at the root: the US Centers for Disease Control and Prevention say that more than 200 respiratory viruses can cause colds, and that rhinoviruses are the most common cause in the United States. Antibiotics were made for bacteria, so in a viral infection they are a drug without a target. Al-Haddad said as much in the same report: antibiotics do not treat viral infections, so the patient takes a drug he does not need.

The cortisone is where the whole story gets explained. Al-Haddad says in the report that it reduces inflammation temporarily and so gives the patient “a false sense of improvement,” and that repeated use can seriously harm people with high blood pressure, heart disease and diabetes. That sentence alone explains why the myth survives: within hours the patient really does feel “back on his feet,” the credit goes to the injection, and yet the cold would have run its course by itself within days. What happened was the muting of symptoms, not the cure of a cause. Al-Haddad also warns against giving such injections in some pharmacies without an allergy test.

Now to the second claim, the one with deeper roots: is the vein inherently stronger? In a paper published in PLOS Medicine in May 2015 under the title “Unsupported preference for intravenous antibiotics,” Ho Kwong Li, Ambrose Agweyu, Mike English and Philip Bejon wrote that this belief has no sound theoretical basis. For widely used classes, the beta-lactams, glycopeptides and macrolides, killing the microbe depends on how long the drug concentration stays above the minimum level that inhibits its growth, not on the peak concentration, and a well-absorbed oral drug can achieve that duration. The strength, then, is not in the needle. It is in the drug and in how much of it reaches the blood.

More importantly, the paper does not stop at theory. It gathers what randomized trials have actually found. Adult trials in pneumonia, both severe and non-severe, showed no advantage for intravenous treatment. Six randomized trials in children with kidney infection, covering 917 children, concluded that early switching to oral treatment was equivalent to staying on intravenous treatment for longer. And 22 randomized trials covering 2,372 patients with low-risk febrile neutropenia found oral treatment, or an early switch to it, to be an acceptable alternative. Later evidence has not overturned that conclusion: a large randomized trial published by the New England Journal of Medicine in 2019, on bone and joint infection, found oral treatment noninferior to intravenous treatment, with fewer complications at the catheter site. All of this concerns antibiotics in medically prescribed cases, not a common cold.

The vein also has its price. The same paper records complications specific to this route alone: inflammation of the vein, leakage of the drug outside it, clotting, and local or systemic infection. Citing a 2006 systematic review by Maki and colleagues, it states that the risk of bloodstream infection may reach 0.1 percent with a peripheral intravenous catheter, 2.4 percent with a peripherally inserted central catheter, and 4.4 percent with a central venous catheter. These are upper limits, not averages, and the per-patient risk is small, but it is not zero. The point is that injection is not the “safer choice” that supposedly cannot hurt.

For anyone who suspects this is foreign talk with no echo here, the official Egyptian position is written down and published. The Egyptian Drug Authority posts on its website a national guide titled “The National Guide for Switching from Intravenous to Oral Antibiotics,” code EDREX: GU.CAP.care.003, first edition, February 2022, issued by the Central Administration of Pharmaceutical Care. The guide sets out criteria for switching from vein to mouth and, in turn, a section on the grounds for continuing intravenous treatment. In other words, switching to oral treatment is a procedure officially endorsed in Egypt, and continuing injections is likewise a decision with specific grounds.

Here is a line without which this debunking should not be read: the route by which a medicine is given is the decision of the treating doctor, not of the patient and not of a relative on the phone. Some cases genuinely require injections: vomiting that prevents the medicine from staying down, a severe infection, hospital admission, or a drug that does not exist in oral form. So nobody should stop a medicine that was prescribed to them, change how it is taken, or refuse an injection their doctor has ordered, because of this article or any news article. If symptoms drag on, worsen or bring something worrying, the road leads to the doctor, not to the pharmacy shelf.

Why write about this at all? Because of the collective bill. The World Health Organization says bacterial resistance to antibiotics was associated with more than 4.7 million deaths worldwide in 2021, according to the Global Burden of Disease analysis of antimicrobial resistance from 1990 to 2021, published in The Lancet in 2024. The organization places misuse and overuse, including taking antibiotics when they are not needed, at the front of what drives resistance forward. So every antibiotic taken for a viral cold is not just a superfluous drug. It is free training for bacteria to resist it just when the patient truly needs it.

In the Egyptian context, what we can reliably cite is small local studies and public appeals, not national figures. A qualitative interview study published in the Journal of Pure and Applied Microbiology in 2018, on the sale of antibiotics without prescription in Alexandria, interviewed pharmacists at 25 randomly selected community pharmacies. All respondents said the practice was common, and 60 percent said the trend was increasing. That is the result for its sample, its city and its year, not “Egypt's rate.” As for the appeals, they belong to their authors and their dates: in a statement dated May 4, 2025, the head of the Egyptian Drug Authority, Dr. Ali al-Ghamrawi, called for strict regulatory policies on the use of antibiotics. We did not find the text of any ministerial decree banning their dispensing without a prescription, so we will not claim that one exists, or that it does not. Our judgment here is one of health and ethics, and it concerns a system and a habit, not any particular pharmacy.

And how can a reader examine such a claim next time? With three simple questions. What exactly is the illness, viral or bacterial, and who says so? What is the evidence that the proposed route is better: a published trial, or a personal feeling of improvement after a few hours? And who holds the information needed for the decision: a two-minute exchange at the pharmacy counter that knows nothing of your medical history, or a clinical examination that asks about chronic illnesses, allergies and the medicines you already take? Diagnosing an illness and choosing the route of a drug are the work of the treating doctor, and the pharmacist is a partner in dispensing and explaining a prescription, not in writing it. The official websites, the Egyptian Drug Authority, the Ministry of Health and the World Health Organization, carry published texts that any reader can check. And next winter, when the same advice arrives by phone, the difference between asking “which one is strongest?” and asking “what exactly do I have?” will be the difference between a decision that comforts you for hours and one that protects you for years.

Share

Related Stories

موجة عالية تتكسر فوق سور بحري خرساني منخفض وتتصاعد رذاذًا أبيض في يمين الصورة، وخلفها بحر هائج تعلوه أمواج بيضاء. شبان يقفون على حافة السور يتابعون الماء، بينما يسير آخرون ويجلسون على مقاعد حجرية فوق ممشى واسع مبللة أجزاء منه. وتمتد عمارات سكنية على طول الواجهة البحرية في خلفية الصورة تحت سماء صافية.
The TruthMisleading

“The nawwat have fixed dates the calendar knows in advance”: misleading. The season is real; the date is not science

Every November the same table returns to our phones: al-Miknasa on 16 November, Qasim on 4 December, as if rain kept an appointment in the calendar. Egypt’s meteorological authority says there is no fixed scientific start date for the nawwat and the names are popular, not official. The table’s attribution also shifts between two bodies, and we could not find it on either site. We debunk the claim, honour the heritage and show how to check.

November 16, 2026 · 8 min read

لقطة قريبة ليدَي امرأة أمام حاسوب محمول: يد على لوحة المفاتيح، ويد تمسك بطاقة بنكية بشريحة، وبجوارهما هاتف ذكي شاشته مطفأة موضوع على اللوحة. لا يظهر وجه ولا أرقام مقروءة على البطاقة ولا محتوى على الشاشة.
The TruthFalse

“Parcel on hold: update your details via the link”: a text that doesn’t update your account but opens it to others

A text says your parcel is stuck or your details need updating; one link will fix it. The claim: a message asking you to update your details through a link is an official message from the post office or bank. Verdict: false. Egypt Post denies asking for confidential data or updates through unofficial links; the Central Bank warns against links and sharing codes. How to read the message, and what to do at once if you entered your details.

November 11, 2026 · 8 min read

ممرضة تُعطي حقنة تطعيم الأنفلونزا الموسمية لموظف في عيادة صحية، وبجانبها صندوق أدوات طبية ومطهر
The TruthFalse

‘The Flu Shot Is What Gives You Flu’ — What’s Actually Inside the Seasonal Vaccine?

With the first chill of autumn and the return to school, the same line comes back: ‘I got the shot and fell ill with flu a week later.’ We examine this one claim: does the seasonal flu vaccine spread the disease? Verdict: false. The reason lies in how the vaccine itself is made, in the two weeks the body needs to build immunity, and in other winter viruses wrongly blamed for it.

November 1, 2026 · 7 min read